CN1225818A - Safety pulp devitalizer - Google Patents

Safety pulp devitalizer Download PDF

Info

Publication number
CN1225818A
CN1225818A CN 98100802 CN98100802A CN1225818A CN 1225818 A CN1225818 A CN 1225818A CN 98100802 CN98100802 CN 98100802 CN 98100802 A CN98100802 A CN 98100802A CN 1225818 A CN1225818 A CN 1225818A
Authority
CN
China
Prior art keywords
pulp
devitalizer
paraformaldehyde
azone
safety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98100802
Other languages
Chinese (zh)
Inventor
华之成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRAL HOSPITAL SHANGHAI RAILWAY BUREAU
Original Assignee
CENTRAL HOSPITAL SHANGHAI RAILWAY BUREAU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTRAL HOSPITAL SHANGHAI RAILWAY BUREAU filed Critical CENTRAL HOSPITAL SHANGHAI RAILWAY BUREAU
Priority to CN 98100802 priority Critical patent/CN1225818A/en
Publication of CN1225818A publication Critical patent/CN1225818A/en
Pending legal-status Critical Current

Links

Abstract

The present invention discloses a safe and effective pulp devitalizer consisting of paraformaldehyde, azone, cocaine, lanolin and gentian violet for curing dental pulp diseases with the advantages of non-toxic and quick-acting, etc..

Description

Safety pulp devitalizer
The present invention is a kind of medicament that is used for the inactivation dental pulp, is used for the treatment of dental pulp disease, has safety, acts on fast advantage, belongs to field of medicaments.
Dental caries is a kind of commonly encountered diseases, frequently-occurring disease.Easy secondary dental pulp disease, produce pain, destroy the integrity of organ of mastication, reduce masticatory function, hinder digestion, thereby cause general disease, very big to human health risk, the treatment of dental pulp disease accounts for the very big part of daily department of stomatology diagnosis and treatment work, and mummification of pulp is still the method that is widely used in pulpal treatment both at home and abroad, and this method must at first make devitalization of dental pulp.8Spooner at first used arsenic trioxide as pulp devitalizer in 1936, and up to the present, the most frequently used deactivator still is an arsenic trioxide.So far, mummification of pulp, especially in European countries and developing country's extensive uses such as Japan, Germany, Switzerland, the former Soviet Unions and is studied in countries in the world.Hans, Herman Rebel has done to be described in detail to various pulp devitalizers, and has thought that devitalization of dental pulp is an indispensable Therapeutic Method on the present clinical position in nearly work " dentistry is preserved and a learned " book.
All conventional both at home and abroad at present arsenic trioxide or the paraformaldehyde inactivation dental pulp of using.Because arsenical toxicity is big, the careless slightly severe complications such as chemical apicitis, periodontium necrosis and gangrenosum acne osteomyelitis that easily cause.Though paraformaldehyde has effect to relax, advantages such as safety, the effect of inactivation dental pulp is too slow, often needs 2-4 week, brings inconvenience to treatment.
The object of the invention provides a kind of safety pulp devitalizer.
For achieving the above object, the present invention utilizes the low toxicity of azone and helps the effect of oozing efficiently, and it and paraformaldehyde with proper proportion, are aided with other drug again and formulate into novel azone paraformaldehyde pulp devitalizer, and concrete prescription is:
Paraformaldehyde: 3-10g
Azone: 0.3-1g
Cocaine: 1-5g
Lanoline: 1-3g
Gentian Violet: 1-3g.
Above-mentioned composition optimum ratio of the present invention is:
Paraformaldehyde: 5g
Azone: 0.5g
Cocaine: 3g
Lanoline: 2g
Gentian Violet: 2.
Azone is a kind of colourless, nontoxic and nearly tasteless oily liquids, and it and other drug merge uses the absorbance that can significantly increase other drug.
Paraformaldehyde is the formaldehyde polymer of linear structure, depolymerization gradually at normal temperatures, and slowly and enduringly bulk storage goes out formaldehyde vapors, act on dental pulp blood vessel endothelium and smooth muscle, distend the blood vessels earlier, make the capable stasis of blood then, the dental pulp dehydration, thus mummification necrosis takes place, make devitalization of dental pulp.Its action temperature and, can not cause the organization of root tips pathological changes.
The azone paraformaldehyde pulp devitalizer that permeation-promoter azone and paraformaldehyde are made by above-mentioned prescription, both preserved the various advantages of paraformaldehyde, and can obviously quicken the deactivation of paraformaldehyde to dental pulp, both had advantage with the quite rapid inactivation dental pulp of arsenic trioxide, but avoided the serious side effects of arsenic trioxide deactivator, become a kind of complete energy and substitute arsenic trioxide, not only be suitable for being grown up but also be suitable for child's safety pulp devitalizer.
Medicine indication of the present invention:
1. chronic ulcerative pulpitis
2. chronic hyperplastic pulpitis
Acute serous pulpitis through pacify the treatment be converted into chronic phase after
4. after acute suppurative pulpitis transfers chronic phase to
Using method: all be used for the perforation of pulp chamber tooth, the envelope medicine time is grasped flexibly according to perforation of pulp chamber point size and patient age.
1.
Figure A9810080200041
Extirpation of pulp, envelope medicine 4 days
2.
Figure A9810080200042
Mummification of pulp envelope medicine 2 days, extirpation of pulp envelope medicine 5 days
3.
Figure A9810080200043
Mummification of pulp: perforation of pulp chamber point is big, envelope medicine 2 days;
Perforation of pulp chamber point is little, 4 days extirpations of pulp of envelope medicine: envelope medicine 7 days.
Over nearly 6 years this deactivator is applied to clinical 1815 examples, the devitalization of dental pulp acceptance rate reaches 95.1%, any complication does not take place, and confirm through zoopery and histopathological study that histopathology that this deactivator causes changes and conform to clinical setting, identify the back continuation in the clinical expansion use, respond well
(1) safety pulp devitalizer of azone paraformaldehyde formation, the advantage such as safe, reliable of having preserved not only that the paraformaldehyde deactivator has, and obviously quickened the deactivation of paraformaldehyde to dental pulp, make time from the 2-4 week of inactivation dental pulp shorten to 2-4 days, shortened the course of treatment greatly, can make deciduous molar and bicuspid devitalization of dental pulp in 1-2 days, 2-4 angel accessional teeth devitalization of dental pulp has reached the same inactivation effect of arsenic trioxide commonly used at present.
(2) this pulp devitalizer safety, nontoxic, have no side effect, even confirming can not to go for some reason envelope to prolong the envelope medicine time to 14, pathology day periodontal tissue and periapical tissue are also had no adverse reaction on time, do not need the strict grasp envelope medicine time as arsenic trioxide, therefore be applicable to that the job site disperses, mobile all patients that can not guarantee further consultation on time in 48 hours greatly.
(3) since this pulp devitalizer to the periapical tissue non-toxic reaction, so more be applicable to the inactivation of deciduous teeth (root of the tooth short) and young permanent teeth (apical foramen of tooth is formation as yet).
(4) this deactivator has very strong bactericidal action, also can be used for infectious devitalization of dental pulp.
(5) this deactivator can not produce pain behind the envelope medicine under the prerequisite that correctly chooses indication.
(6) use azone paraformaldehyde deactivator, when opening marrow and emedullate painless, no oozing of blood, get a clear view, easy to operate, oozing of blood is many when opening marrow than arsenic trioxide, the unclear superiority that has more in the visual field, and because of no oozing of blood, so the invariant color of inactivation future trouble tooth is more suitable in making labial teeth inactivation extirpation of pulp.
In view of above situation, the safety pulp devitalizer that the azone paraformaldehyde constitutes obviously is better than conventional at present arsenic trioxide or the paraformaldehyde pulp devitalizer of using, be a kind of complete energy substitute them both be suitable for the child, be suitable for again being grown up fast, safety, ideal pulp devitalizer.
Embodiment:
Paraformaldehyde: 5 grams
Azone: 0.5 gram
Cocaine: 3 grams
Lanoline: 2 grams
Gentian Violet: 2.
Above-mentioned paraformaldehyde 5 grams are placed mortar, add azone 0.5 gram and give uniform mixing earlier, add cocaine 3 gram uniform mixing then, add lanoline 2 grams again and reconcile into dried pasty state, add 2 of Gentian Violets at last and make paste be deep blue Lycoperdon polymorphum Vitt to get final product.

Claims (3)

1, a kind of safety pulp devitalizer is characterized in that it comprises the component of following weight ratio:
Paraformaldehyde: 3-10
Azone: 0.3-1
Cocaine: 1-5
Lanoline: 1-3
Gentian Violet: 1-3 drips.
2,, it is characterized in that the proportioning of each component is according to the pulp devitalizer of claim 1:
Paraformaldehyde: 5
Azone: 0.5
Cocaine: 3
Lanoline: 2
Gentian Violet: 2.
3, a kind of compound method of safety pulp devitalizer is characterized in that: by described prescription, paraformaldehyde is placed mortar, add azone and give uniform mixing earlier, add the cocaine uniform mixing then, add lanoline again and reconcile into dried pasty state, add Gentian Violet at last and make paste be deep blue Lycoperdon polymorphum Vitt to get final product.
CN 98100802 1998-02-10 1998-02-10 Safety pulp devitalizer Pending CN1225818A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98100802 CN1225818A (en) 1998-02-10 1998-02-10 Safety pulp devitalizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98100802 CN1225818A (en) 1998-02-10 1998-02-10 Safety pulp devitalizer

Publications (1)

Publication Number Publication Date
CN1225818A true CN1225818A (en) 1999-08-18

Family

ID=5216258

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98100802 Pending CN1225818A (en) 1998-02-10 1998-02-10 Safety pulp devitalizer

Country Status (1)

Country Link
CN (1) CN1225818A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100464734C (en) * 2006-11-20 2009-03-04 赵志凌 Desensitizing anticarious gel and its prepn

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100464734C (en) * 2006-11-20 2009-03-04 赵志凌 Desensitizing anticarious gel and its prepn

Similar Documents

Publication Publication Date Title
Malamed The periodontal ligament (PDL) injection: an alternative to inferior alveolar nerve block
Zachrisson Clinical experience with direct-bonded orthodontic retainers
Cozzani Extraoral traction and Class III treatment
Remmer et al. Cephalometric changes associated with treatment using the activator, the Fränkel appliance, and the fixed appliance
Mortada et al. A simplified technique for the restoration of severely mutilated primary anterior teeth
Friedman et al. Five root canals in a mandibular first molar
Froum et al. Histologic response to intraligament injections using a computerized local anesthetic delivery system. A pilot study in mini‐swine
Tronstad et al. Surgical access for endodontic treatment of intruded teeth
Di Felice et al. Gingival and mandjbular bone necrosis caused by a paraformaldehyde‐containing paste
Knibbs Glass ionomer cement: 10 years of clinical use
AsokAN et al. Crown dilaceration of maxillary right permanent central incisor: a case report
Follin et al. Occurrence and distribution of root resorption in orthodontically moved premolars in dogs
CN1225818A (en) Safety pulp devitalizer
Brown The management of traumatically intruded permanent incisors in children
Eliasson et al. Autotransplanted teeth with early-stage endodontic treatment: a radiographic evaluation
Elíasson et al. Rubber-base impression material as a foreign body: Report of a case
Nasjleti et al. Effects of composite restorations on the periodontal membrane in monkeys
Lowe Dental cements: an overview
JP3157153B2 (en) Dental treatment material
Barbakow et al. Histologic response of replanted teeth pretreated with acidulated sodium fluoride
Vergara et al. Preservation of esthetics with implant dentistry: a clinical report
Cardoso Clinical and laboratory techniques for repair of fractured porcelain in fixed prostheses: a case report.
Hülsmann et al. Periodontal destruction and tooth loss following pulp devitalization with Toxavit: report of a case
Harris Treatment of a Cracked Tooth with a Resin-lonomer Restoration and a Connective Tissue Graft: A Case Report.
Meeran An efficient technique of bonding orthodontic attachments to surgically exposed impacted teeth

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication